TREM2 and prostate adenocarcinoma: Lastly, analysis of drug sensitivity showed significant differences for 6 drugs, with all values being lower in the HRG.<h4>Conclusion</h4>This study identified TREM2, FNDC1, and S100A8 as key MPT-driven necrosis-related genes predicting biochemical recurrence in PRAD.